Patents by Inventor Antonio F. CRUZ

Antonio F. CRUZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR TREATMENT OF RENAL DISEASE
    Publication number: 20230096602
    Abstract: Methods of treating renal disease or treating at least one of muscle wasting, low muscle strength, or low physical function in a subject having renal disease by administering at least one tetrahydrocyclopenta[b]indole compound are disclosed. Also disclosed are methods of treating symptoms as a result of secondary hypogonadism induced by renal replacement therapy or kidney failure in a subject having renal disease by administering at least one tetrahydrocyclopenta[b]indole compound.
    Type: Application
    Filed: January 26, 2021
    Publication date: March 30, 2023
    Applicant: Eirgen Pharma Ltd.
    Inventors: Antonio F. CRUZ, Phillip FROST
  • TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BHP
    Publication number: 20180185347
    Abstract: Methods of treating the signs and symptoms of Benign Prostatic Hyperplasia (BPH) in a subject by administering at least one tetrahydrocyclopenta[b]indole compound are disclosed. Also disclosed are methods of treating the signs and symptoms of BPH in a subject by administering at least one tetrahydrocyclopenta[b]indole compound in combination with a phosphodiesterase type-5 inhibitor.
    Type: Application
    Filed: November 15, 2017
    Publication date: July 5, 2018
    Applicant: Transition Therapeutics (Ireland 2) Limited
    Inventors: Antonio F. CRUZ, Phillip FROST